TNB
TEVA icon

Thomasville National Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Thomasville National Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,175
Closed -$135K – 312
2015
Q1 		$135K Buy
+2,175
New +$126K 0.05% 160
2014
Q3 		– Sell
-5,325
Closed -$279K – 136
2014
Q2 		$279K Sell
5,325
-3,500
-40% -$179K 0.1% 115
2014
Q1 		$466K Sell
8,825
-2,000
-18% -$92.4K 0.19% 83
2013
Q4 		$434K Buy
10,825
+375
+4% +$14.8K 0.19% 81
2013
Q3 		$395K Buy
+10,450
New +$408K 0.21% 89

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Thomasville National Bank's TEVA Position: Q2 2015 in Review

Thomasville National Bank sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 2,175 shares — an estimated $135K sold.

Thomasville National Bank first reported a position in TEVA in Q3 2013 and held it in 5 quarters. The position peaked at $466K in Q1 2014. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

  • Thomasville National Bank reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Thomasville National Bank sold 2,175 Teva Pharmaceuticals shares in Q2 2015, an estimated $135K.
  • Thomasville National Bank first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Thomasville National Bank's Teva Pharmaceuticals position peaked at $466K in Q1 2014.
  • 818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Thomasville National Bank's 13F filing for Q2 2015, filed 22 Jul 2015.